10 questions answered from cited research · Plain language
A large review of seven studies found that taking NSAIDs during pregnancy is linked to a higher risk of kidney disease in children, with the risk increasing when used in the second and third trimesters.
Read the full answer →Yes, the 2025 EAU guidelines update kidney cancer care with new recommendations on stereotactic body radiotherapy, adjuvant therapy, and systemic treatments for clear-cell and hereditary RCC.
Read the full answer →Artificial intelligence helps kidney cancer patients by improving tumor detection on scans, planning robotic surgeries, and predicting surgical outcomes to reduce complications.
Read the full answer →Yes, elderly patients have higher risks of sepsis after PCNL, but overall complication rates are similar to younger patients for most kidney stone surgeries.
Read the full answer →Yes, complement pathways are involved in kidney transplant rejection, including antibody-mediated rejection, and may be targeted for therapy.
Read the full answer →Obesity fuels kidney inflammation through adipose tissue dysfunction, lipotoxicity, altered secretion of inflammatory factors, and gut-derived uremic toxins, creating a vicious cycle that worsens chronic kidney disease.
Read the full answer →Yes, layered data models that combine clinical, lab, medication, and social data can help doctors detect diabetic kidney disease risk earlier than traditional methods alone.
Read the full answer →Yes, a machine learning model using routine hospital data can detect hidden diabetic kidney disease, even when standard tests appear normal.
Read the full answer →Yes, pentoxifylline may improve kidney function and reduce inflammation in chronic kidney disease, based on meta-analyses showing modest eGFR increase and lower inflammatory markers.
Read the full answer →Yes, HIF-PHIs lower LDL and total cholesterol in CKD patients, but meta-analyses show no significant reduction in cardiovascular death or heart attack risk.
Read the full answer →